June 2018 FDA Recall Naloxone Hydrochloride by Hospira Inc, Lake Forest
D-0906-2018 - Presence of Particulate Matter; Potential for particulate matter on the syringe plunger.

This Class I drug recall was voluntarily initiated by Hospira Inc, Lake Forest on June 4, 2018 for the product Naloxone Hydrochloride. The FDA reported the reason for recall as presence of particulate matter; potential for particulate matter on the syringe plunger.. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0906-2018

Reason for Recall
Presence of Particulate Matter; Potential for particulate matter on the syringe plunger.
Initiated
06-04-2018
Reported
06-13-2018
Quantity
164,860 syringes

Recall Profile & Regulatory Data

Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
HOSPIRA INC, LAKE FOREST
Nationwide in the U.S., Puerto Rico, and Guam
Naloxone Hydrochloride Injection, USP, 0.4 mg/mL, 1 mL in 2.5 mL Carpuject Single-use cartridge syringe, Single unit (NDC 0409-1782-03) and 10 count box (NDC 0409-1782-69), Rx Only, Hospira Inc., Lake Forest, IL

Batch or Lot Expiration Information

Lot# 72680LL, Exp. 1DEC2018 (NDC 0409-1782-03); 76510LL, Exp. 1APR2019 (NDC 0409-1782-69)